FDA Application
-
NDC Search Results on Active Ingredient: ibuprofen
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
ACETAMINOPHEN; IBUPROFEN | 0573-0145-99 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
DIPHENHYDRAMINE CITRATE; IBUPROFEN | 0573-0164-21 | Haleon US Holdings LLC | NDA021394 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0169-17 | Haleon US Holdings LLC | NDA020402 | HUMAN OTC DRUG | NDA |
IBUPROFEN; ACETAMINOPHEN | 0573-0147-09 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
IBUPROFEN SODIUM | 0573-0230-40 | Haleon US Holdings LLC | NDA201803 | HUMAN OTC DRUG | NDA |
DIPHENHYDRAMINE CITRATE; IBUPROFEN | 0573-0164-40 | Haleon US Holdings LLC | NDA021394 | HUMAN OTC DRUG | NDA |
DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN | 0573-0167-21 | Haleon US Holdings LLC | NDA021393 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-1769-09 | Haleon US Holdings LLC | NDA020402 | HUMAN OTC DRUG | NDA |
DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN | 0573-0167-18 | Haleon US Holdings LLC | NDA021393 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; IBUPROFEN | 0573-0145-18 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN | 0573-0167-26 | Haleon US Holdings LLC | NDA021393 | HUMAN OTC DRUG | NDA |
DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN | 0573-0167-44 | Haleon US Holdings LLC | NDA021393 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0151-05 | Haleon US Holdings LLC | NDA018989 | HUMAN OTC DRUG | NDA |
DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN | 0573-0167-43 | Haleon US Holdings LLC | NDA021393 | HUMAN OTC DRUG | NDA |
IBUPROFEN SODIUM | 0573-0133-80 | Haleon US Holdings LLC | NDA201803 | HUMAN OTC DRUG | NDA |
IBUPROFEN; ACETAMINOPHEN | 0573-0147-86 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
DIPHENHYDRAMINE CITRATE; IBUPROFEN | 0573-0164-08 | Haleon US Holdings LLC | NDA021394 | HUMAN OTC DRUG | NDA |
DIPHENHYDRAMINE CITRATE; IBUPROFEN | 0573-0164-30 | Haleon US Holdings LLC | NDA021394 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0169-30 | Haleon US Holdings LLC | NDA020402 | HUMAN OTC DRUG | NDA |
IBUPROFEN; ACETAMINOPHEN | 0573-0147-18 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0169-51 | Haleon US Holdings LLC | NDA020402 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0165-31 | Haleon US Holdings LLC | NDA018989 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0290-30 | Haleon US Holdings LLC | NDA020589 | HUMAN OTC DRUG | NDA |
IBUPROFEN SODIUM | 0573-0133-89 | Haleon US Holdings LLC | NDA201803 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0166-85 | Haleon US Holdings LLC | NDA018989 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0207-30 | Haleon US Holdings LLC | NDA020589 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0168-20 | Haleon US Holdings LLC | NDA020402 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0154-98 | Haleon US Holdings LLC | NDA018989 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0160-40 | Haleon US Holdings LLC | NDA018989 | HUMAN OTC DRUG | NDA |
IBUPROFEN | 0573-0169-13 | Haleon US Holdings LLC | NDA020402 | HUMAN OTC DRUG | NDA |
-